Analysis of breast cancer survival by clinical response to neoadjuvant chemoendocrine therapy

Ann Oncol. 2006 Feb;17(2):352-3; author reply 353-4. doi: 10.1093/annonc/mdj010. Epub 2005 Aug 19.

Authors

J Bogaerts, R Sylvester, P Therasse

PMID: 16113059
DOI: 10.1093/annonc/mdj010

No abstract available

Publication types

Comment
Letter

MeSH terms

Antineoplastic Agents, Hormonal / therapeutic use*
Breast Neoplasms / drug therapy*
Female
Humans
Neoadjuvant Therapy*
Survival Analysis

Substances

Antineoplastic Agents, Hormonal